Insider Transactions in Q2 2021 at Ideaya Biosciences, Inc. (IDYA)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,893
-3.79%
|
$85,646
$22.49 P/Share
|
|
Jun 17
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,893
+3.65%
|
$23,358
$6.92 P/Share
|
|
Jun 16
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,107
-1.11%
|
$24,354
$22.47 P/Share
|
|
Jun 16
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,107
+1.1%
|
$6,642
$6.92 P/Share
|
|
Jun 07
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.5%
|
$30,000
$20.22 P/Share
|
|
Jun 07
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+1.47%
|
$9,000
$6.92 P/Share
|
|
May 28
2021
|
Paul A. Stone Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
859
+5.86%
|
$9,449
$11.36 P/Share
|
|
May 11
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.82%
|
$100,000
$20.22 P/Share
|
|
May 11
2021
|
Michael P. Dillon SVP, Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.6%
|
$30,000
$6.92 P/Share
|